A vaccination strategy for the long-term suppression of androgens in advanced prostate cancer.
Parkinson, R J
A vaccination strategy for the long-term suppression of androgens in advanced prostate cancer. [electronic resource] - European urology Feb 2004 - 171-4; discussion 174-5 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Controlled Clinical Trial; Journal Article
0302-2838
10.1016/j.eururo.2003.10.007 doi
Androgen Antagonists--therapeutic use
Cancer Vaccines--administration & dosage
Diphtheria Toxoid--chemistry
Disease Progression
Dose-Response Relationship, Drug
Gonadotropin-Releasing Hormone--chemistry
Humans
Male
Oligopeptides--chemistry
Prostate-Specific Antigen--blood
Prostatic Neoplasms--blood
Testosterone--blood
A vaccination strategy for the long-term suppression of androgens in advanced prostate cancer. [electronic resource] - European urology Feb 2004 - 171-4; discussion 174-5 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Controlled Clinical Trial; Journal Article
0302-2838
10.1016/j.eururo.2003.10.007 doi
Androgen Antagonists--therapeutic use
Cancer Vaccines--administration & dosage
Diphtheria Toxoid--chemistry
Disease Progression
Dose-Response Relationship, Drug
Gonadotropin-Releasing Hormone--chemistry
Humans
Male
Oligopeptides--chemistry
Prostate-Specific Antigen--blood
Prostatic Neoplasms--blood
Testosterone--blood